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SUMMARY – Th e purpose is to report on the safety and effi  cacy of Ahmed Glaucoma Valve 
(AGV, New World Medical, Inc., Rancho Cucamonga, CA, USA) implantation for the management 
of refractory pediatric glaucoma observed during one-year follow up period. A retrospective chart 
 review was conducted on 10 eyes, all younger than 11 years, with pediatric glaucoma that underwent 
AGV implantation for medicamentously uncontrolled intraocular pressure (IOP) between 2010 and 
2014. Outcome measures were control of IOP below 23 mm Hg (with or without antiglaucoma 
medications) and changes in visual acuity. Complications were recorded. After AGV implantation, 
IOP values ranged from 18 mm Hg to 23 mm Hg (except for one eye with postoperative hypotonia 
due to suprachoroid hemorrhage, where the postoperative IOP value was 4 mm Hg). Th e number of 
antiglaucoma medications was reduced, i.e. four patients had two medications, one patient had one 
medication, and the others did not need antiglaucoma medication on the last follow-up visit. One eye 
had suprachoroid hemorrhage, one eye had long-term persistent uveitic membrane, and two eyes had 
tube-cornea touch. In conclusion, AGV implantation appears to be a viable option for the manage-
ment of refractory pediatric glaucoma and shows success in IOP control. However, there was a rela-
tively high complication rate limiting the overall success rate.
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Introduction
Pediatric glaucoma is a potentially blinding disease, 
which is often refractory to medical treatment. Al-
though traditional surgical procedures for the manage-
ment of pediatric glaucoma, such as goniotomy, tra-
beculotomy, and combined trabeculotomy and trabec-
ulectomy have high success rates when performed as 
initial surgical procedures1,2, many of the children with 
pediatric glaucoma will require other forms of surgical 
therapy to achieve adequate control of intraocular 
pressure (IOP). Some of the more refractory second-
ary pediatric glaucomas, such as those associated with 
anterior segment dysgenesis, aniridia, Sturge-Weber 
syndrome, and following congenital cataract surgery, 
show poor results using these surgical approaches3,4.
Glaucoma drainage devices have become popular 
in the management of these glaucomas. Th e Molteno, 
Ahmed and Baerveldt implants are currently the most 
popular implants used in the management of refrac-
tory glaucoma.
Th e purpose of this study was to evaluate the effi  -
cacy of the Ahmed Glaucoma Valve implant (AGV, 
New World Medical Inc., Rancho Cucamonga, CA, 
USA) in pediatric patients with refractory glaucoma 
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related to IOP control, changes in visual acuity, and 
complications during one-year follow up period.
Subjects and Methods
A retrospective chart review was conducted on 10 
eyes in nine consecutive pediatric patients with refrac-
tory glaucoma treated with AGV implantation from 
2010 to 2014 at the Clinical Department of Ophthal-
mology, Sestre milosrdnice University Hospital Cen-
ter, Zagreb, Croatia. Th ere were six boys and four girls, 
all younger than 11 years. Th e retrospective review of 
patient charts for this study was approved by the Hos-
pital Ethics Board. All surgeries were performed by 
the same surgeon (Z.M.), who was also present at all 
follow up examinations.
Th ere were 4 eyes with secondary aphakic glauco-
ma, 3 eyes were pseudophakic with uncontrolled IOP, 
1 eye had secondary uveitic glaucoma, and 2 eyes had 
primary congenital glaucoma.
Combined trabeculotomy with trabeculectomy 
procedure was previously performed in each eye, and 
trabeculectomy with trabeculotomy at 6 o’clock posi-
tion was also previously performed in 2 eyes. All study 
subjects had uncontrolled IOP, which means more 
than 21 mm Hg despite maximal medical therapy (≥3 
topical antiglaucoma medications).
Surgery was performed under general anesthesia in 
all eyes using the S-3 model (pediatric size of AGV). 
Th e implant was placed in the superior-temporal 
quadrant in all eyes except for one eye where it was 
placed in the supero-nasal quadrant, at a distance of 
8-10 mm from the limbus. Th en scleral fl ap was formed 
to cover the external surface of the tube. Th e tube was 
inserted into the anterior chamber, after being primed 
with balanced salt solution, using a 23 gauge needle, 
parallel to the iris surface, into the ciliary sulcus. Th e 
tube was fi xed to the sclera using 10-0 nylon suture 
and conjunctiva was repositioned and sutured.
In the immediate postoperative period, patients re-
ceived topical atropine combined with topical cortico-
steroids and antibiotic preparations that were tapered 
slowly over a 4-week period.
Each patient was reviewed within the week before 
surgery and daily for the fi rst 5 postoperative days at a 
minimum. After that, patients were examined 3 to 4 
weeks after surgery and at various intervals thereafter 
until the fi nal visit, with minimum follow up of 1 year. 
Intraocular pressure was measured awake using Gold-
mann applanation tonometer or under general anes-
thesia when patients were uncooperative for evalua-
tion. Perkins tonometer was only used for examina-
tions under anesthesia.
Complete success was defi ned as IOP between 6 
mm Hg and 21 mm Hg without medications and no 
loss of vision due to complications such as choroid 
hemorrhage or phthisis during the follow up period. 
Qualifi ed success included cases in which the above 
criteria were fulfi lled with the addition of glaucoma 
medications. Failures were defi ned as IOP <6 mm Hg 
or >18 mm Hg, loss of light perception, loss of vision 
due to complications, removal of the implant or the 
need for further surgical intervention for IOP control 
including cyclodestructive procedures.
Th e following data were extracted from medical re-
cords: age, sex, type of glaucoma, visual acuity mea-
surements when available (before and after surgery), 
details of slit lamp examination or under the operating 
microscope (before and after surgery), IOP measure-
ment obtained with Perkins or Goldmann applanation 
tonometry (before and after surgery), optic disk and 
fundus evaluation, and axial length measurements 
when available (before and after surgery). Th e number 
of topical antiglaucoma medications before and after 
surgery, was also noted in medical records. Details of 
surgeries performed prior to AGV implantation were 
noted. Operative details included the model of the im-
plant used, the quadrant in which it was placed, and 
intraoperative surgical complications, if any. Postop-
erative details included visual acuity, IOP measure-
ments, number of medications, complications, and ad-
ditional interventions in the postoperative period.
Results
Table 1 summarizes data recorded in the study. 
Th ere were 4 eyes with secondary aphakic glaucoma, 3 
eyes were pseudophakic with uncontrolled IOP, 1 eye 
had secondary uveitic glaucoma, and 2 eyes had pri-
mary congenital glaucoma (1P, 2P). Visual acuity was 
the same before and at the end of follow up period. 
IOP values before AGV implantation ranged from 25 
mm Hg to 38 mm Hg despite maximal medical ther-
apy. After AGV implantation, IOP values were from 
18 mm Hg to 23 mm Hg (except for 1 eye with post-
operative hypotonia due to suprachoroid hemorrhage, 
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where the postoperative IOP value was 4 mm Hg). 
Th e number of antiglaucoma medications was reduced 
in postoperative period, i.e. four patients had two 
medications, one patient had one antiglaucoma medi-
cation, and the others did not need antiglaucoma med-
ication on the last follow-up visit. Table 1 also shows 
fi nal outcome where success was defi ned as IOP <21 
mm Hg and the success rate was 50%. Figure 1 shows 
normal postoperative fi nding after AGV implantation.
In our study, only one eye had a fl at anterior cham-
ber and hypotonia secondary to suprachoroid hemor-
rhage. Th e preoperative IOP in this eye was 37 mm 
Hg, and postoperative hypotonia was 4 mm Hg (pre-
viously mentioned patient) (Table 1, Fig. 2). Th ere 
were two patients with tube-cornea contact (Table 1, 
Fig. 3). Th is occurred early in our case series and the 
rate of tube contact has since been reduced by modify-
ing surgical protocol to place the tube more posteri-
orly in the anterior chamber. Th e tube contact tended 
to occur in buphthalmic eyes of very young patients, 
perhaps because of the reduced scleral rigidity and an-
terior migration of the anterior chamber tube with 
postoperative pressure reduction, which allowed 
shrinkage of the stretched sclera and globe5.
One patient had uveitic membrane in the early 
postoperative period, which resolved after two months 
(Fig. 4), and one patient had hyphema, which resolved 
during the fi rst postoperative week (Fig. 5).
Table 1. Postoperative patient data








1 P 0.15150.15 30/22 2 None Cyclodestruction Failure
2 P 0.15 29/23 2 None Cyclodestruction Failure
3 0.15 26/18 0 None None Success
4 0.075 28/20 1 None None Success
5 0.075 25/20 0 None None Success
6 L+P+ 35/21 2 Tube-cornea touch Cyclodestruction Failure
7 L+P- 34/23 2 Tube-cornea touch None Failure
8 Lost eye 37/4 0 Suprachoroid hemorrhage None Failure
9 0.15 38/21 0 None – early hyphema None Success
10 L+P+ 32/21 2 Uveitic membrane None Success
IOP = intraocular pressure; P = primary congenital glaucoma
Fig. 2. Flat anterior chamber secondary to suprachoroid 
hemorrhage.
Fig. 1. Normal postoperative fi nding with visible tube 
in anterior chamber.
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Discussion
Glaucoma drainage implants are useful when other 
surgical treatments have a poor prognosis for success, 
prior conventional surgery fails, or when signifi cant 
conjunctival scarring precludes fi ltration surgery. Stud-
ies of glaucoma drainage implants in pediatric patients 
report success rate ranging from 56% to 95%, depend-
ing on patient age, type of glaucoma, variations in the 
defi nition of success, and length of follow up6-10. How-
ever, complications have been associated with drainage 
implants in pediatric patients. Reported complications 
include hypotonia with fl at anterior chamber and cho-
roid detachment, tube-cornea touch and corneal ede-
ma, obstructed tube, exposed tube or plate, endo-
phthalmitis, and retinal detachment. Postoperatively, 
Fig. 3. Tube-cornea contact 
(whitish area on superotemporal cornea).
Fig. 4. Uveitic membrane in pseudophakic eye 
with glaucoma.
Fig. 5. Postoperative hyphema.
patients often require adjunctive glaucoma medica-
tions5. In the study, we had one patient with fl at ante-
rior chamber due to suprachoroid hemorrhage and 
none of the other eyes had shallow or fl at anterior 
chamber that required reformation during the study. 
Shallow or fl at anterior chambers can be diffi  cult to 
manage in pediatric patients, and additional anesthesia 
is often necessary. Also, we had two patients with 
tube-cornea contact due to postoperative tube migra-
tion (typically anteriorly). Other studies report this 
complication in 26% to 35% of patients11-13. Th is phe-
nomenon is more likely in the elastic infant eye than in 
the older child or adult5. In the present study, there 
were no other complications.
Th e World Glaucoma Association guidelines for 
reporting success rates following glaucoma surgical 
procedures recommend several alternatives for the up-
per limit (<21 mm Hg, 18 mm Hg, 15 mm Hg and 12 
mm Hg), and one for the lower limit (6 mm Hg)14. 
Most reports on the use of AGV in pediatric eyes use 
an upper limit of 21 mm Hg to 23 mm Hg and lower 
limit of <5 mm Hg with or without medications to 
defi ne success, and report success rates of 70% to 94% 
using these defi nitions15. In our series, 50% of the eyes 
had successful control of IOP at the fi nal visit using 
these defi nitions. Although these patients required ad-
junctive glaucoma medications to achieve satisfactory 
IOP, they had no need for additional surgical interven-
tion during the one-year follow up period.
Our study had the limitations of retrospective de-
sign, mixture of preoperative diagnoses, and a relative-
ly small sample size. Collected data were limited to 
those that were available in medical records.
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Sažetak
POČETNO KLINIČKO ISKUSTVO S IMPLANTACIJOM AHMEDOVE GLAUKOMSKE VALVULE 
KOD REFRAKTORNOG GLAUKOMA DJEČJE DOBI
K. Novak-Lauš, J. Škunca Herman, M. Šimić Prskalo, D. Jurišić i Z. Mandić
Svrha rada je prikazati sigurnost i učinkovitost implantacije Ahmedove glaukomske valvule (AGV, New World Medical, 
Inc., Rancho Cucamonga, CA, SAD) kod refraktornog glaukoma dječje dobi tijekom jednogodišnjeg praćenja. Proveden je 
retrospektivni pregled nalaza 10 očiju u djece mlađe od 11 godina u kojih je ugrađena AGV zbog medikamentima nekontro-
liranog glaukoma u razdoblju od 2010. do 2014. godine. Pratila se visina intraokularnog tlaka (IOT) i vidna oštrina, a također 
su bilježene komplikacije. Rezultati su pokazali da su nakon implantacije AGV vrijednosti IOT-a bile od 18 mm Hg do 23 
mm Hg (osim kod jednog oka s poslijeoperacijskom hipotonijom zbog suprakoroidnog krvarenja, gdje je poslijeoperacijski 
IOT bio 4 mm Hg). Broj antiglaukomskih lijekova bio je smanjen: četvoro bolesnika su imali po dva lijeka, jedan je imao 
jedan lijek, a svi ostali nisu trebali dodatne lijekove na posljednjem pregledu. Kod jednog oka se pojavilo suprakoroidno 
 krvarenje, kod jednog dugotrajna upalna membrana, a kod dva oka kontakt cjevčice s rožnicom. Zaključuje se da implan tacija 
AGV predstavlja izbor u liječenju refraktornog glaukoma dječje dobi i ima uspjeha u kontroli IOT-a. Međutim, relativno 
velik broj komplikacija ograničava konačan uspjeh.
Ključne riječi: Ahmedova glaukomska valvula; Glaukom, dječja dob; Intraokularni tlak, medikamentno nekontroliran; Glaukom 
– kirurgija
